Cathleen Anema

Cathleen Anema serves as the Director of Access and Reimbursement for the North Central Region at TG Therapeutics, Inc., where leadership in access and reimbursement initiatives focuses on enhancing patient access through strategic solutions and internal collaboration. Previous roles include Associate Director of Access and Reimbursement at TG Therapeutics, Field Reimbursement Manager at AstraZeneca, and Senior Territory Business Manager at Bristol Myers Squibb, where expertise in minimizing reimbursement barriers and supporting product launches was demonstrated. With extensive experience in the biotech and pharmaceutical industries, including positions at Genentech and UCB, Cathleen has a proven track record in developing educational programs, managing complex reimbursement issues, and optimizing patient access across various therapeutic areas. Academic qualifications include a BS in Biological Science with a focus on Health Education from Western Michigan University.